Peter P. Pfreundschuh
2020 - UroGen Pharma Ltd.
Compensation breakdown
Non-Equity Incentive Plan | $218,800 |
---|---|
Option Awards | $292,055 |
Salary | $324,329 |
Stock Awards | $176,460 |
Other | $152,313 |
Total | $1,163,956 |
Pfreundschuh received $324.3K in salary, accounting for 28% of the total pay in 2020.
Pfreundschuh also received $218.8K in non-equity incentive plan, $292.1K in option awards, $176.5K in stock awards and $152.3K in other compensation.
Rankings
In 2020, Peter P. Pfreundschuh's compensation ranked 7,986th out of 13,090 executives tracked by ExecPay. In other words, Pfreundschuh earned more than 39.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,986 | 39th |
Manufacturing | 3,388 | 40th |
Chemicals And Allied Products | 1,369 | 39th |
Drugs | 1,191 | 39th |
Pharmaceutical Preparations | 884 | 39th |
Pay ratio
Peter P. Pfreundschuh's Pay | $1,163,956 |
---|---|
Median Employee's Pay | $222,109 |
Pay Ratio | 5to 1 |
In 2020, the annual total compensation of Peter P. Pfreundschuh was $1,163,956.
The annual total compensation of the median employee at UroGen Pharma Ltd. was $222,109.
The ratio of Peter P. Pfreundschuh's pay to the pay of median employee was therefore 5 to one.
Pfreundschuh's colleagues
We found five more compensation records of executives who worked with Peter P. Pfreundschuh at UroGen Pharma Ltd. in 2020.
2020
Elizabeth Barrett
UroGen Pharma Ltd.
Chief Executive Officer
2020
Jason Smith
UroGen Pharma Ltd.
General Counsel
2020
Molly Henderson
UroGen Pharma Ltd.
Chief Financial Officer
2020
Mark Schoenberg
UroGen Pharma Ltd.
Chief Medical Officer
2020
Stephen Mullennix
UroGen Pharma Ltd.
Chief Operating Officer
News
April 29, 2021
April 28, 2021
April 29, 2020
April 26, 2019